Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Operating Margin (2018 - 2025)

Historic Operating Margin for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 558.64%.

  • Bicycle Therapeutics' Operating Margin rose 18272300.0% to 558.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 5056.14%, marking a year-over-year increase of 82807600.0%. This contributed to the annual value of 17489.33% for FY2024, which is 139054500.0% down from last year.
  • Bicycle Therapeutics' Operating Margin amounted to 558.64% in Q3 2025, which was up 18272300.0% from 2965.82% recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Operating Margin ranged from a high of 331.81% in Q4 2023 and a low of 2965.82% during Q2 2025
  • Moreover, its 5-year median value for Operating Margin was 703.66% (2025), whereas its average is 835.67%.
  • Its Operating Margin has fluctuated over the past 5 years, first surged by 18695400bps in 2022, then plummeted by -24675100bps in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Operating Margin (Quarter) stood at 2253.0% in 2021, then soared by 83bps to 383.46% in 2022, then soared by 187bps to 331.81% in 2023, then tumbled by -33bps to 222.82% in 2024, then plummeted by -351bps to 558.64% in 2025.
  • Its last three reported values are 558.64% in Q3 2025, 2965.82% for Q2 2025, and 703.66% during Q1 2025.